Related Experiment Video
Updated: Jul 24, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
Personalizing precision medicine: Patients with AML perceptions about treatment decisions
Åsa Grauman1, Mika Kontro2, Karl Haller3
1Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Patients with acute myeloid leukemia desire more information for shared decision-making in precision medicine. Lack of knowledge hinders involvement, emphasizing the physician
Area of Science:
- Oncology
- Genetics
- Medical Ethics
Background:
- Acute myeloid leukemia (AML) presents complex treatment decisions.
- Precision medicine offers personalized therapeutic strategies for AML.
- Patient involvement in shared decision-making is evolving.
Purpose of the Study:
- To explore AML patients' perceptions of precision medicine.
- To understand patient preferences for involvement in precision medicine decision-making.
- To identify barriers and facilitators for patient engagement.
Main Methods:
- Semi-structured interviews conducted across three European countries (Finland, Italy, Germany).
- Study included 16 patients aged 24-79 years.
- Thematic content analysis used to analyze interview data.
Main Results:
- Patients perceive a lack of knowledge as a significant barrier to decision-making.
- Treatment choices are often based on physician trust and intuition, especially in urgent situations.
- Patients express willingness to accept treatments with low cure probabilities due to their critical condition.
Conclusions:
- Patients' understanding of precision medicine and involvement in decision-making pose significant challenges.
- While technical advancements are welcomed, the physician's role as a trusted expert remains paramount.
- Effective patient education is crucial for enhancing perceived involvement in precision medicine.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Treatment Resistant Cancers
Cancer Survival Analysis
Patient-centered Care